CLEXIO BIOSCIENCES
Clexio Biosciences is a clinical-stage pharmaceutical company that integrates drugs and new technologies to deliver clinical benefits to patients. The company was founded in 2018 and is based in Jerusalem, Israel.
CLEXIO BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-03-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.clexio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Holy Stone Healthcare
Holy Stone Healthcare is developing lifesaving therapeutics and targeted delivery technologies to improve the quality of life .
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Current Employees Featured
Founder
Official Site Inspections
http://www.clexio.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Clexio Biosciences"
About Us - Clexio
About Clexio Clexio is a clinical-stage company designing novel drugs based on validated Mechanisms of Action in NeuroPsychiatry. We are developing innovative therapies to address …See details»
Clexio Biosciences - Crunchbase Company Profile
Organization. Clexio Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Clexio Biosciences …See details»
Clexio Biosciences - The Org
Clexio Biosciences is a CNS-first clinical-stage pharmaceutical company. Our therapies are designed to address patients’ unmet needs through scientifically based integration of drugs …See details»
Clexio Biosciences - Israeli Startup | Startup Nation Finder
Oct 23, 2024 Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. …See details»
Clexio Biosciences - Overview, News & Similar companies
Who is Clexio Biosciences. Clexio Biosciences is a clinical-stage pharmaceutical company dedicated to the development of novel treatments designed to deliver clinical benefit s to …See details»
Clexio Biosciences Ltd.
Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel therapies for patients suffering from neurological and psychiatric conditions. Learn More …See details»
Clexio Biosciences - Leadership Team - The Org
The Leadership Team at Clexio Biosciences, comprising the Chief Medical Officer, CEO and Co-founder, and VP Business Development, spearheads the strategic direction and operational …See details»
Clexio Biosciences Ltd. - Drug pipelines, Patents, Clinical ... - Patsnap
May 7, 2025 Explore Clexio Biosciences Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 3 news, and 2 literature, Disease Domain:Nervous System Diseases, …See details»
Clexio Biosciences - 2025 Company Profile - Tracxn
May 13, 2025 Clexio is a developer of therapeutics for treating pain, depression and other CNS disorders. The products pipeline includes CLE-100 (an oral NMDA modulator) to treat the …See details»
Clexio Biosciences - Psychedelic Finance
Clexio identifies points of convergence between validated mechanisms of action and technology, to generate new patient-centric possibilities. Clexio Biosciences multidisciplinary team brings …See details»
Clexio - VentureRadar
"We are a multi-asset, CNS-first clinical stage pharmaceutical company that grew out of an R&D team at a Big Pharma company. We are dedicated to developing novel drugs and …See details»
Clexio Biosciences Company Profile | Management and ... - Datanyze
Clexio Biosciences is a clinical-stage pharmaceutical company dedicated to the development of novel treatments designed to deliver clinical benefits to patients through sophisticated …See details»
Clexio Biosciences - Contacts, Employees, Board Members
Organization. Clexio Biosciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 12. ... Clexio …See details»
Clexio Biosciences Ltd.
Clexio is a clinical-stage company designing novel drugs based on validated Mechanisms of Action in NeuroPsychiatry. We are developing innovative therapies to address patients’ unmet …See details»
Pipeline - Clexio
Everything we do is driven by patients and what they have to live with. We innovate and refine solutions that can be integrated in a seamless way into patients’ lives.See details»
Clexio | VentureRadar
Website: https://www.clexio.com/ We are a multi-asset, CNS-first clinical stage pharmaceutical company that grew out of an R&D team at a Big Pharma company.See details»
Clexio Biosciences - Tech Stack, Apps, Patents & Trademarks
Mar 10, 2025 The intellectual property of Clexio Biosciences includes 64 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. …See details»
Clinical Trials - Clexio
Recently Clexio partnered with the Depression Bipolar Support Alliance (DBSA) to evaluate the readability of the Inform Consent Form (ICF) designed for our Ph2 trial in patients suffering …See details»
News Archive - Clexio
Clexio Biosciences expands its protection of CLE-100 with the issuance of a third US method of use patent and the allowance of an additional three US patents. 10 April 2024 Clexio initiates …See details»
Publications & Presentations - Clexio
A Phase 2 Randomized Controlled Adjunctive Treatment Trial with CLE-100 Esketamine Tablet for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants, …See details»